Crossmark

Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)

Crossref DOI link: https://doi.org/10.1038/s41598-019-38575-x

Published Online: 2019-02-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Siddiqui, Mohammad R.

Railkar, Reema

Sanford, Thomas

Crooks, Daniel R.

Eckhaus, Michael A.

Haines, Diana

Choyke, Peter L.

Kobayashi, Hisataka https://orcid.org/0000-0003-1019-4112
Agarwal, Piyush K.
Funding

Funding for this research was provided by:

NIH Medical Research Scholars Program

U.S. Department of Health & Human Services | NIH | National Cancer Institute (ZIABC011458-02)
License Information

Text and Data Mining valid from 2019-02-14

Version of Record valid from 2019-02-14
More Information

Article History

Received: 14 September 2018

Accepted: 28 December 2018

First Online: 14 February 2019

Competing Interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below